Evidence map›Paper›PMID 25052832›Full record

Trial reportJournal of thrombosis and thrombolysis2015

Platelet function in Takotsubo cardiomyopathy.

Iván J Núñez-Gil, Esther Bernardo, Gisela Feltes, Javier Escaned, Hernán D Mejía-Rentería, José Alberto De Agustín, David Vivas, Luis Nombela-Franco, Pilar Jiménez-Quevedo, Carlos Macaya and 1 more

Abstract readClinical TrialComparative StudyMulticenter Study
PubMed Publisher
In one paragraph

Trial report in Journal of thrombosis and thrombolysis, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 1 synthesis or guideline pooled it, 24 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Analysis ofFrontiers in cardiovascular medicine · 2023
    Article
  6. Atrial thrombosis during Tako-tsubo cardiomyopathy: chance or plausible risk?Clinical research in cardiology : official journal of the German Cardiac Society · 2021
    Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Anticoagulation and stress-induced cardiomyopathy.Journal of thrombosis and thrombolysis · 2019
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Iván J Núñez-GilCardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain, ibnsky@yahoo.es.
Esther Bernardo
Gisela Feltes
Javier Escaned
Hernán D Mejía-Rentería
José Alberto De Agustín
David Vivas
Luis Nombela-Franco
Pilar Jiménez-Quevedo
Carlos Macaya
Antonio Fernández-Ortiz
Hospital Clínico San Carlos · ESUniversidad Complutense de Madrid · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Takotsubo cardiomyopathy (TK) includes a transient left ventricular dysfunction without obstructive coronary disease, sometimes after stressful situations with elevated cathecolamines. Since catecholamines activate platelets we aimed to study the platelet influence in a TK setting. We included 32 patients with a TK diagnosis, 13 with an acute coronary syndrome (ACS) and 18 healthy volunteers. Once consent informed was obtained, blood samples were extracted and processed (at admission and after 3 months follow-up). Clinical, ecg, echocardiographic and angiographic features were thoroughly recorded.Previous treatment before admission was similar between groups. No differences were observed in clinical features or any of the acute markers studied regarding platelet reactivity between TK compared to ACS. After follow-up, aggregation levels and platelet reactivity showed differences, mainly due to the antithrombotic therapy prescribed at discharge, but similar to volunteers. Circulating epinephrine during the acute phase was significantly higher in TK (p < 0.001). Patients with higher levels of epinephrine had elevated platelet activation and aggregation after 3 months. No differences were observed in Takotsubo acute platelet aggregation compared to patients with ACS, in spite of higher blood levels of adrenaline. Takotsubo patients had elevated platelet aggregation and activation compared with ACS patients at 3 months follow-up because they were less frequently on chronic clopidogrel and ASA. However, they had similar platelet aggregation and activation levels to healthy volunteers despite treatment with low-dose ASA. Takotsubo patients who had higher levels of adrenaline in the acute phase displayed increased platelet reactivity during follow-up.

Indexed as

Platelet AggregationRegistriesAcute Coronary SyndromeAgedAged, 80 and overBlood PlateletsClopidogrelEpinephrineFemaleFollow-Up StudiesHumansMaleMiddle AgedPlatelet Aggregation InhibitorsPlatelet Function TestsProspective StudiesClopidogrelEpinephrinePlatelet Aggregation InhibitorsTiclopidine

Identifiers

PMID25052832
OpenAlexW2093398504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.